Structure-/disease-modifying agents for osteoarthritis

Roy D Altman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalSeminars in Arthritis and Rheumatism
Volume34
Issue number2 SUPPL.
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Osteoarthritis
Joints
Cartilage Diseases
Inflammation
Therapeutics
Population

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Structure-/disease-modifying agents for osteoarthritis. / Altman, Roy D.

In: Seminars in Arthritis and Rheumatism, Vol. 34, No. 2 SUPPL., 10.2004, p. 3-5.

Research output: Contribution to journalArticle

Altman, Roy D. / Structure-/disease-modifying agents for osteoarthritis. In: Seminars in Arthritis and Rheumatism. 2004 ; Vol. 34, No. 2 SUPPL. pp. 3-5.
@article{fe19c66d98ac4f49b05e6c16fbe1bb22,
title = "Structure-/disease-modifying agents for osteoarthritis",
abstract = "OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions.",
author = "Altman, {Roy D}",
year = "2004",
month = "10",
doi = "10.1016/j.semarthrit.2004.03.002",
language = "English (US)",
volume = "34",
pages = "3--5",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Structure-/disease-modifying agents for osteoarthritis

AU - Altman, Roy D

PY - 2004/10

Y1 - 2004/10

N2 - OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions.

AB - OA is the most common articular disease. Age is its most notable risk factor. With the aging of the population of the developed world, there will be a growing need for better understanding of OA and for superior therapies. There is increasing appreciation for the role of inflammation in OA. There also is the realization that OA is not only a disease of cartilage, but of the entire joint. This has led to increasing interest in structure/disease modification as the goal in OA therapy. However, there are no universally proven structure-/disease-modifying interventions.

UR - http://www.scopus.com/inward/record.url?scp=19344365995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344365995&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2004.03.002

DO - 10.1016/j.semarthrit.2004.03.002

M3 - Article

VL - 34

SP - 3

EP - 5

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 2 SUPPL.

ER -